1. Home
  2. ICCC vs VNCE Comparison

ICCC vs VNCE Comparison

Compare ICCC & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • VNCE
  • Stock Information
  • Founded
  • ICCC 1982
  • VNCE 2002
  • Country
  • ICCC United States
  • VNCE United States
  • Employees
  • ICCC N/A
  • VNCE N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • ICCC Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • ICCC 60.1M
  • VNCE 20.2M
  • IPO Year
  • ICCC 1987
  • VNCE 2013
  • Fundamental
  • Price
  • ICCC $6.71
  • VNCE $1.43
  • Analyst Decision
  • ICCC
  • VNCE Strong Buy
  • Analyst Count
  • ICCC 0
  • VNCE 3
  • Target Price
  • ICCC N/A
  • VNCE $4.17
  • AVG Volume (30 Days)
  • ICCC 41.8K
  • VNCE 108.7K
  • Earning Date
  • ICCC 08-12-2025
  • VNCE 06-17-2025
  • Dividend Yield
  • ICCC N/A
  • VNCE N/A
  • EPS Growth
  • ICCC N/A
  • VNCE N/A
  • EPS
  • ICCC N/A
  • VNCE N/A
  • Revenue
  • ICCC $27,302,766.00
  • VNCE $292,214,000.00
  • Revenue This Year
  • ICCC N/A
  • VNCE $1.54
  • Revenue Next Year
  • ICCC N/A
  • VNCE $3.74
  • P/E Ratio
  • ICCC N/A
  • VNCE N/A
  • Revenue Growth
  • ICCC 28.29
  • VNCE 1.46
  • 52 Week Low
  • ICCC $3.34
  • VNCE $1.02
  • 52 Week High
  • ICCC $7.60
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 49.68
  • VNCE 47.37
  • Support Level
  • ICCC $5.63
  • VNCE $1.23
  • Resistance Level
  • ICCC $7.14
  • VNCE $1.46
  • Average True Range (ATR)
  • ICCC 0.64
  • VNCE 0.15
  • MACD
  • ICCC -0.06
  • VNCE 0.01
  • Stochastic Oscillator
  • ICCC 42.58
  • VNCE 58.57

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: